
Converge Bio
The Generative AI Lab for the Life Sciences
Tel Aviv, Israel · Founded 2024 · $30.5M raised
- Headquarters
- Tel Aviv
- Employees
- 11–50
- Founded
- 2024
- Business Model
- B2B
- Website
- converge-bio.com
- Total Funding
- $30.5M
- Last Round
- $25.0M Series AJan 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.
About
Converge Bio is an AI-driven drug discovery company founded in 2024 and headquartered in Tel Aviv, Israel with a presence in Boston, Massachusetts. The company provides a generative AI lab for life sciences, helping pharmaceutical and biotech customers accelerate drug development through AI-powered molecule design, discovery, and manufacturing optimization. Founded by CEO Dov Gertz, CTO Oded Kalev, and CSO Iddo Weiner, Converge Bio raised a $5.5M seed in 2024 and a $25M Series A in January 2026 led by Bessemer Venture Partners. The company has completed over 40 programs with more than a dozen pharma and biotech clients globally.
Summary
Converge Bio is an Artificial Intelligence company based in Tel Aviv, Israel, founded in 2024. It has raised $30.5M in total across 2 rounds, most recently a $25.0M Series A round in Jan 2025. Investors include TLV Partners, Bessemer Venture Partners and Vintage Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2025
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/converge-bio"><img src="https://indexed.vc/api/badge/company/converge-bio" alt="Converge Bio on Indexed.vc" width="260" height="76" /></a>



